BMS’s Revlimid Loss Of Exclusivity Is Not As Bad As Expected, But Not For Long

 
• By Alaric DeArment
  
earnings report
BMS announced its first quarter earnings on 29 April • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip